Rapid Generation of Retinal Pigmented Epithelium for Retinal Disease Therapy
- Technology Benefits
- Highly efficient and rapid conversion of human embryonic stem cells to retinal tissue cells A potentially unlimited source of RPE for transplant therapy from human embryonic and induced pluripotent stem cells
- Technology Application
- Cellular therapy for degenerative retinal diseases Degenerative retinal disease research This technology is available for licensing.
- Detailed Technology Description
- Researchers at the University of California, Santa Barbara have developed a novel method for rapid and efficient differentiation of human embryonic stem cells into retinal pigmented epithelium. This method yields RPE in the majority of stem cells treated in only half of the time documented for the most efficient methods. The speed and efficiency of the method gives it the potential to significantly advance the fields of research dealing with the causes and therapies for degenerative retinal diseases (e.g. age-related macular degeneration).
- Application No.
- 9458428
- Others
-
Background
Retinal Pigmented Epithelium (RPE) cells can be created from human embryonic and induced pluripotent stem cells. It has been shown, however, that the transformation of these stem cells into RPE is inefficient and very time consuming. Research into degenerative retinal diseases would benefit greatly from a more timely and efficient method for producing RPE from human embryonic stem cells.
Additional Technologies by these Inventors
Tech ID/UC Case
22139/2012-019-0
Related Cases
2012-019-0
- *Abstract
-
A novel method for rapid and efficient differentiation of human embryonic stem cells into retinal pigmented epithelium.
- *IP Issue Date
- Oct 4, 2016
- *Principal Investigator
-
Name: David Buchholz
Department:
Name: Dennis Clegg
Department:
Name: Roxanne Croze
Department:
Name: Britney Pennington
Department:
Name: Peter Coffey
Department:
Name: Lindsay Leach
Department:
- Country/Region
- USA
